Trump administration suffers setbacks on drug price transparency efforts

Modern Healthcare: The Trump administration last week hit a couple of major roadblocks in its effort to combat high drug prices. Attempts to increase price transparency are now in murky waters.

A federal judge ruled July 8 that HHS didn’t have the authority to mandate that drugmakers disclose list prices in TV ads. U.S. District Judge Amit Mehta said Congress must act first and give HHS permission to promulgate such a rule.

Read article